US FDA Drug Development Tool Qualification Takes Center Stage At December Meeting
Executive Summary
Public session to gather input on taxonomy and scientific criteria for qualifying animal models, biomarkers and clinical outcome assessments is early step toward satisfying 21st Century Cures Act requirements and PDUFA VI commitments.